Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Addressing financial toxicity and time toxicity among patients with multiple myeloma

Rahul Banerjee, MD, Fred Hutchinson Cancer Center, Seattle, WA, discusses a study which evaluated financial toxicity and time toxicity in patients with multiple myeloma. Dr Banerjee highlights that financial toxicity was found to be fairly stable among patients, and interestingly, time toxicity was reported in patients on active therapy as well as patients on maintenance therapy. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Consulting/advisory: SparkCures, Sanofi Pasteur, Genentech/Roche, Janssen Oncology, Bristol-Myers Squibb/Celgene, Caribou Biosciences, Pfizer
Research funding: Pack Health